Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-1-30
|
pubmed:abstractText |
Repetitive local application of a short train of stimuli to the rat substantia nigra and ventral tegmental area elicited a predominant depolarizing, slow, long-lasting synaptic response in the dopaminergic cells intracellularly recorded in vitro. This slow excitatory postsynaptic potential ranged between 13 and 27 mV at holding potentials of about-75 mV and lasted for 0.2-6 s. It was not greatly affected by the perfusion of 6-cyano-7-nitroquinoxaline-2,3-dione (10-20 microM), while it was potentiated in the presence of bicuculline methiodide (30 microM) or picrotoxin (50-100 microM) and 2-hydroxysaclofen (100-300 microM). In contrast, a substantial component of the slow excitatory postsynaptic potential was reversibly depressed, in a concentration-dependent manner, by the application of the N-methyl-D-aspartate receptor antagonists D,1-2-amino-5-phosphonovalerate (10-100 microM). Furthermore, the slow excitatory postsynaptic potential was reversibly increased by the superfusion of nominally magnesium-free solution. It was graded, increasing in amplitude with increased stimulus intensity, and was blocked by tetrodotoxin (0.5 microM). We suggest that a sustained activation of synaptic terminals containing excitatory amino acids mediates a slow excitatory postsynaptic potential in the dopaminergic cells of the midbrain. N-Methyl-D-aspartate receptors participate in the generation of this slow potential, while the alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionate/kainate receptors do not seem to contribute substantially to this potential. This N-methyl-D-aspartate-mediated synaptic event could be implicated in the release of dopamine as well as in the excitotoxic injury of the dopaminergic neurons.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-Amino-5-phosphonovalerate,
http://linkedlifedata.com/resource/pubmed/chemical/6-Cyano-7-nitroquinoxaline-2,3-dione,
http://linkedlifedata.com/resource/pubmed/chemical/Bicuculline,
http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Ketamine,
http://linkedlifedata.com/resource/pubmed/chemical/Picrotoxin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, N-Methyl-D-Aspartate,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrodotoxin,
http://linkedlifedata.com/resource/pubmed/chemical/bicuculline methiodide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0306-4522
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
785-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8884774-2-Amino-5-phosphonovalerate,
pubmed-meshheading:8884774-6-Cyano-7-nitroquinoxaline-2,3-dione,
pubmed-meshheading:8884774-Animals,
pubmed-meshheading:8884774-Bicuculline,
pubmed-meshheading:8884774-Dopamine,
pubmed-meshheading:8884774-Electric Stimulation,
pubmed-meshheading:8884774-Evoked Potentials,
pubmed-meshheading:8884774-Excitatory Amino Acid Antagonists,
pubmed-meshheading:8884774-Ketamine,
pubmed-meshheading:8884774-Membrane Potentials,
pubmed-meshheading:8884774-Mesencephalon,
pubmed-meshheading:8884774-Neurons,
pubmed-meshheading:8884774-Picrotoxin,
pubmed-meshheading:8884774-Rats,
pubmed-meshheading:8884774-Rats, Wistar,
pubmed-meshheading:8884774-Receptors, N-Methyl-D-Aspartate,
pubmed-meshheading:8884774-Substantia Nigra,
pubmed-meshheading:8884774-Synapses,
pubmed-meshheading:8884774-Synaptic Transmission,
pubmed-meshheading:8884774-Tegmentum Mesencephali,
pubmed-meshheading:8884774-Tetrodotoxin,
pubmed-meshheading:8884774-Time Factors
|
pubmed:year |
1996
|
pubmed:articleTitle |
N-methyl-D-aspartate receptors mediate a slow excitatory postsynaptic potential in the rat midbrain dopaminergic neurons.
|
pubmed:affiliation |
Clinica Neurologica Dip. Sanita' Pubblica, Universita' di Roma Tor Vergata, Italy.
|
pubmed:publicationType |
Journal Article,
In Vitro
|